Improving Neuropsychological Rehabilitation for COVID-19 Patients
Open Access
- 1 June 2023
- journal article
- review article
- Published by Hogrefe Publishing Group in Zeitschrift für Neuropsychologie
- Vol. 34 (2), 57-70
- https://doi.org/10.1024/1016-264x/a000373
Abstract
Cognitive sequelae after recovery from an initial COVID-19 disease are present in a subset of affected individuals, coalescing around several important issues such as effects of age, COVID-19 disease severity, comorbidities, and other factors. Some neuropsychological symptoms appear more common among certain patient populations. Comorbidities may complicate neuropsychological assessment as well. Hence, we need a guideline-based evaluation to guide neuropsychological rehabilitation. Drawing from the recent revision of the German National Guideline for the Long- and Post-COVID Syndrome and current advances in international guidance on neuropsychological assessment, this article provides practical and scientifically informed recommendations for the neuropsychological assessment of individuals recovering from coronavirus-related diseases.Keywords
This publication has 76 references indexed in Scilit:
- Clinical Presentation and Outcomes of Severe Acute Respiratory Syndrome Coronavirus 2–Related Encephalitis: The ENCOVID Multicenter StudyThe Journal of Infectious Diseases, 2020
- Neuropsychological Features of Severe Hospitalized Coronavirus Disease 2019 Patients at Clinical Stability and Clues for Postacute RehabilitationArchives of Physical Medicine and Rehabilitation, 2020
- Post-intensive care syndrome and COVID-19 — Implications post pandemicCleveland Clinic Journal of Medicine, 2020
- Immediate and long-term consequences of COVID-19 infections for the development of neurological diseaseAlzheimer's Research & Therapy, 2020
- Influencia de la infección SARS-CoV-2 sobre enfermedades neurodegenerativas y neuropsiquiátricas: ¿una pandemia demorada?Neurología, 2020
- Systematic review of COVID‐19 in children shows milder cases and a better prognosis than adultsActa Paediatrica, 2020
- Characterizing Apolipoprotein E ε4 Carriers and Noncarriers With the Clinical Diagnosis of Mild to Moderate Alzheimer Dementia and Minimal β-Amyloid Peptide Plaques.JAMA Neurology, 2015
- Brain morphology links systemic inflammation to cognitive function in midlife adultsBrain, Behavior, and Immunity, 2015
- Peripheral Cytokines and Chemokines in Alzheimer’s DiseaseDementia and Geriatric Cognitive Disorders, 2009
- High interleukin‐6 plasma levels are associated with functional impairment in older patients with Vascular dementiaInternational Journal of Geriatric Psychiatry, 2006